These patients use this drug to survive, doctors started to attempt to hoard it in order to provide it. This pill that can be made for just pennies, started at $1.00, then jumped to $13.50 and then $750 when Turing bought it. They are a free market settlement. Turing is able to exclude buyers from using this service. There was a switch from drugstores to controlled distribution made in June by Impax, not by Turing. Still, controlled distribution was a strategy Mr. Shkreli talked about at his previous company as a way to prevent generics. Some hospitals say they now have trouble getting the drug. The only financial incentive to conserve the resource is profitability for the
These patients use this drug to survive, doctors started to attempt to hoard it in order to provide it. This pill that can be made for just pennies, started at $1.00, then jumped to $13.50 and then $750 when Turing bought it. They are a free market settlement. Turing is able to exclude buyers from using this service. There was a switch from drugstores to controlled distribution made in June by Impax, not by Turing. Still, controlled distribution was a strategy Mr. Shkreli talked about at his previous company as a way to prevent generics. Some hospitals say they now have trouble getting the drug. The only financial incentive to conserve the resource is profitability for the